Literature DB >> 27610929

Serum Calprotectin Expression as a Diagnostic Marker for Sepsis in Postoperative Intensive Care Unit Patients.

Lifeng Huang1, Jinfeng Li2, Yue Han1, Song Zhao1, Yue Zheng1, Feng Sui1, Xin Xin1, Wenliang Ma1, Yijia Jiang1, Yongming Yao3, Wenxiong Li1.   

Abstract

The research was performed to explore the diagnosis value of dynamic serum calprotectin (SC) expression for sepsis in postoperative intensive care unit patients. One hundred sixty-three patients who met the inclusion criteria served as the study group. All cases in the study group were further divided into the sepsis subgroup (51 cases) and the nonsepsis subgroup (112 cases). Fifty healthy volunteers served as the control group. The levels of SC and other laboratory indexes including complete blood counts, leukocytes, the immature-to-total-neutrophil ratio, procalcitonin (PCT), C-reactive protein, and blood lactate were detected, cytokines [interleukin (IL)-2, IL-6, and interferon-γ] released by neutrophils were also determined. The Acute Physiology and Chronic Health Evaluation II (APACHE II) score and the Sequential Organ Failure Assessment score were calculated. The factors related to prognosis were analyzed with multivariate logistic regression analysis. The diagnostic accuracies of ΔSC [the differences of SC levels between postoperative day (POD) 1 and POD 2, 3, 5, 7] and ΔPCT (the differences of PCT levels between POD 1 and POD 2, 3, 5, 7) on sepsis were compared with other markers for sepsis. The levels of SC and cytokines were markedly increased on POD 1, 2, 3, 5, and 7 in the study group compared with the control group (P < 0.05 or P < 0.01). The same results were found in the sepsis subgroup compared with the nonsepsis subgroup (P < 0.05 or P < 0.01). Significant positive correlations between SC and cytokines were confirmed in patients of the study group (P < 0.05 or P < 0.01). APACHE II scores and the levels of SC and PCT on POD 1 were the variables significantly associated with sepsis. The diagnostic accuracies of ΔSC1-3 (sensitivity 87%, specificity 89%) and ΔPCT1-3 (sensitivity 89%, specificity 90%) for sepsis were greater than other ΔSCs and ΔPCTs. It appears that the dynamic changes in SC are of the predictive values for septic patients after major surgeries.

Entities:  

Keywords:  calprotectin; cytokines; immunity; inflammation; postoperative; sepsis

Mesh:

Substances:

Year:  2016        PMID: 27610929     DOI: 10.1089/jir.2016.0037

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

Review 2.  Role of microRNAs in sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Inflamm Res       Date:  2017-03-03       Impact factor: 4.575

Review 3.  Biomarkers of sepsis: time for a reappraisal.

Authors:  Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

4.  Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV - pilot study.

Authors:  Faith W Kamau; Agnes Gwela; Andrew K Nyerere; Victor Riitho; James M Njunge; Moses M Ngari; Andrew J Prendergast; James A Berkley
Journal:  Wellcome Open Res       Date:  2020-11-27

5.  Aging, Cutaneous Burn Injury and Multi-Organ Complications: The Role of the Gut.

Authors:  Rachel H McMahan; Devin M Boe; Travis M Walrath; Juan-Pablo Idrovo; Elizabeth J Kovacs
Journal:  Adv Geriatr Med Res       Date:  2022-06-28

6.  Early kinetics of calprotectin in plasma following inguinal hernia surgery.

Authors:  Kristina Sejersen; Aleksandra Havelka; Pearl Sanchez Salas; Anders Larsson
Journal:  Innate Immun       Date:  2022-02-01       Impact factor: 2.680

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.